Marketing-authorisation holder · United States
Mylan Labs Ltd
16 medicines in 1 country, as authorisation holder.
Loading your page…
Loading your page…
Marketing-authorisation holder · United States
16 medicines in 1 country, as authorisation holder.
One free account for the Prognia apps: Ward to study, Osler for clinical answers with their sources, and the network to find your colleagues.
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
Every medicine in the registers under its name, current ones first.
16 medicines
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| CIMDUO300mg; 300mg · Tablet | Lamivudine, Tenofovir disoproxil | United States | Marketed | 2018 |
| COBICISTAT150mg · Tablet | Cobicistat | United States | Not marketed | 2024 |
| FLUCONAZOLE IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER100mg/50ml (2mg/ml) | 200mg/100ml (2mg/ml) | 400mg/200ml (2mg/ml) · Injectable | Fluconazole | United States | Marketed | 2003 |
| IRON SUCROSE100mg iron/5ml (eq 20mg iron/ml) | 200mg iron/10ml (eq 20mg iron/ml) | 50mg iron/2.5ml (eq 20mg iron/ml) · Injectable | Iron sucrose | United States | Marketed | 2025 |
| LEVETIRACETAM IN SODIUM CHLORIDE1.5GM/100ML (15MG/ML) | 1GM/100ML (10MG/ML) | 250MG/50ML (5MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | 500MG/100ML (5MG/ML) · Injectable | Levetiracetam | United States | Marketed | 2011 |
| LOPINAVIR AND RITONAVIR100mg; 25mg | 200mg; 50mg · Tablet | Lopinavir, Ritonavir | United States | Marketed | 2021 |
| MOXIFLOXACIN HYDROCHLORIDE IN SODIUM CHLORIDE 0.8% IN PLASTIC CONTAINER400mg/250ml (1.6mg/ml) · Solution | Moxifloxacin | United States | Marketed | 2017 |
| NORGESTREL AND ETHINYL ESTRADIOL0.03mg; 0.3mg | 0.05mg; 0.5mg · Tablet | Ethinyl estradiol, Norgestrel | United States | Not marketed | 2016 |
| SYMFI600mg; 300mg; 300mg · Tablet | Efavirenz, Lamivudine, Tenofovir disoproxil | United States | Marketed | 2018 |
| TRIAMCINOLONE ACETONIDE10mg/ml | 3mg/ml | 40mg/ml · Injectable | Triamcinolone | United States | Marketed | 1981 |
| ABACAVIR AND LAMIVUDINE120mg; 60mg · Tablet | Abacavir, Lamivudine | United States | tentative | 2014 |
| ABACAVIR SULFATE; LAMIVUDINE600mg; 300mg | 60mg; 30mg · Tablet | Abacavir, Lamivudine | United States | tentative | 2008 |
| ATAZANAVIR SULFATE;RITONAVIR;LAMIVUDINE;ZIDOVUDINE300mg; 100mg; 150mg; 300mg · Tablet | Atazanavir, Ritonavir, Lamivudine, Zidovudine | United States | tentative | 2014 |
| BIVALIRUDIN250mg/vial · Injectable | Bivalirudin | United States | tentative | 2017 |
| EMTRICITABINE AND TENOFOVIR ALAFENAMIDE10mg | 120mg | 15mg | 200mg | 25mg · Tablet | Emtricitabine, Tenofovir alafenamide | United States | tentative | 2024 |
| LAMIVUDINE; ZIDOVUDINE30mg; 60mg · Tablet | Lamivudine, Zidovudine | United States | tentative | 2014 |
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| United States | 16 | 10 | 6 | CompaniesAll medicines |
The active substances in most of its medicines.
How the registers spell it, normalised: legal forms, accents and capitals removed.
Compiled by Prognia from the public medicine and company registers below. Logos are not used.
Source: U.S. FDA, Drugs@FDA / openFDA. FDA does not endorse this site.
Licence: Public domain (U.S. Government work)
Report an error or request removalCorrections from the company itself are welcome.
Ranked by their number of medicines.